Group A streptococcal infections of the skin: molecular advances but limited therapeutic progress

Current Opinion in Infectious Diseases
Bart J Currie

Abstract

With the sequencing of several Streptococcus pyogenes (group A Streptococcus) genomes have come major advances in understanding the pathogenesis of group A Streptococcus-associated diseases. This review focuses on group A Streptococcus skin infections and summarizes data published in the English language medical literature in 2004 and 2005. Group A Streptococcus shows enormous and evolving molecular diversity driven by horizontal transmission between group A Streptococcus strains and between group A Streptococcus and other streptococci. Acquisition of prophages accounts for much of the diversity, conferring both virulence through phage-associated virulence factors and increased bacterial survival against host defences. Studies of group A Streptococcus isolates outside the US also question the generalizability of classic group A Streptococcus M serotype associations with specific disease entities such as acute rheumatic fever and necrotizing fasciitis. The distinction between throat and skin group A Streptococcus has become blurred. Although there have been few advances in treatment of group A Streptococcus skin infections, developments towards group A Streptococcus vaccines are promising. The diversity of group A Streptococcus ...Continue Reading

References

Dec 23, 2003·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Ximena BerríosIngrid Riedel
Feb 21, 2004·The Journal of Infectious Diseases·Per AkessonBertil Christensson
Mar 5, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jessica DarenbergAnna Norrby-Teglund
Mar 12, 2004·Clinical and Diagnostic Laboratory Immunology·Julie L WeiszHarry R Hill
Mar 31, 2004·The Lancet Infectious Diseases·Malcolm McDonaldJonathan R Carapetis
Apr 20, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Igor A GuchevOleg I Klochkov
Jul 10, 2004·BMJ : British Medical Journal·Michael J Sladden, Graham A Johnston
Aug 12, 2004·JAMA : the Journal of the American Medical Association·Karen L KotloffJames B Dale
Aug 25, 2004·International Journal of Antimicrobial Agents·Rainer GattringerApostolos Georgopoulos
Sep 17, 2004·Scandinavian Journal of Infectious Diseases·Sang-Ho ChoiNam Joong Kim
Sep 25, 2004·BMJ : British Medical Journal·Sander Koning, Johannes C van der Wouden
Nov 6, 2004·Journal of Clinical Microbiology·Rebecca J TowersPeter K Fagan
Dec 23, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nilay DeyHarpreet Vohra
Jan 26, 2005·Proceedings of the National Academy of Sciences of the United States of America·Paul SumbyJames M Musser
Jan 29, 2005·The Journal of Investigative Dermatology·Marissa H BraffRichard L Gallo
Feb 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Phillip H A LeeRichard L Gallo
Mar 12, 2005·American Journal of Infection Control·Carolyn M GreeneKate E Arnold
Apr 9, 2005·BMJ : British Medical Journal·Saiidy HashamNick B Hart
May 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maria de Fatima S P de OliveiraAchilea L Bittencourt
May 17, 2005·Microbes and Infection·Mark R DaviesKadaba S Sriprakash
May 24, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Janet R Casey, Michael E Pichichero

❮ Previous
Next ❯

Citations

Aug 29, 2006·Current Infectious Disease Reports·Donald C Vinh, John M Embil
Jun 26, 2012·Current Infectious Disease Reports·Manisha PandeyMichael F Good
Feb 13, 2010·Current Opinion in Rheumatology·Annette H M van der Helm-van Mil
Oct 2, 2007·Dermatologic Clinics·Eleonora RuoccoMaria Antonietta Tufano
Jun 22, 2007·Heart, Lung & Circulation·Malcolm McDonaldJonathan R Carapetis
Aug 28, 2007·International Journal of Surgery·Itzhak Brook
Apr 26, 2013·Vaccine·James B DaleAna Maria Henao-Restrepo
Jun 10, 2008·FEMS Immunology and Medical Microbiology·Hercules MouraJohn R Barr
Nov 18, 2017·Viral Immunology·Amber M Smith, Victor C Huber
May 12, 2010·Laboratory Investigation; a Journal of Technical Methods and Pathology·Yueh-Hsia LuoYee-Shin Lin
May 3, 2018·Journal of Ophthalmic & Vision Research·Shirin Hamed-AzzamDavid H Verity
Mar 7, 2009·The Journal of the American Academy of Orthopaedic Surgeons·Joseph M BellapiantaRichard Uhl

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.